In focus

Current topic

---

Research-based pharmaceutical industry in Europe to celebrate 30. anniversary at Annual Meetings
Review of success and first results of EFPIA’s AIMS roadmap
In his address on the occasion of EFPIA’s 30th anniversary, EFPIA President and CEO of Bayer Healthcare Arthur Higgins showcased some of the historic milestones amongst the numerous achievements in the history of the Federation since 1978 – the year artificial insulin was discovered. more

Further information and background details

---

06/20/2008
Research-based pharmaceutical industry in Europe to celebrate 30. anniversary at Annual Meetings
EFPIA President Higgins highlighted pharmaceutical industry’s contribution to health and wealth of EU citizens more

---

01/28/2008
Bayer HealthCare supports IFPMA Assistance to the WHO-based Special Programme for Research and Training in Tropical Diseases (TDR)
Bayer HealthCare has donated a six-figure sum to the WHO-based Special Programme for Research and Training in Tropical Diseases (TDR), co-sponsored by UNICEF, UNDP, the World Bank and WHO. more

---

11/20/2007
Bayer HealthCare joins the European Alliance for Access to Safe Medicines
ASM launch in Brussels on November 20 The European Alliance for Access to Safe Medicines (EAASM) was formally launched in the European Parliament on November 20 at a dinner debate hosted by Bill Newton Dunn MEP. more

---

11/19/2007
EU Conference on Pharmaceutical Innovation - Press Statement Higgins
Press Statement from Arthur Higgins to the EU Conference on Pharmaceutical Innovation more

---

11/19/2007
EU Conference on Pharmaceutical Innovation - Keynote Address Higgins
Keynote Address from Arthur Higgins to the EU Conference on Pharmaceutical Innovation more

---

06/28/2007
Aspirin Award 2007
Professor Hans-Christoph Diener receives the 2007 International Aspirin® Award Bayer HealthCare honors outstanding research into acetylsalicylic acid
Professor Hans-Christoph Diener is the winner of the 2007 International Aspirin® Award. more

---

07/02/2007
EFPIA - demands on information to patients
EFPIA calls for a modern and comprehensive Community framework for information about health and medicinal products
The pharmaceutical industry stands ready to play a responsible role in the provision of non promotional, high-quality health information, and thus respond to the European citizens’ legitimate right to benefit from such information. more

---

06/26/2007
2007 Pharmaceutical Forum
Time to move from debate to action!
The time has come for clear-cut decisions and concrete action if Europe wants to make a comeback as world leader in pharmaceutical innovation. more

---

06/19/2007
Investor Day 2007
Bayer HealthCare strategy presented Update on Bayer Schering Pharma Pipeline
On June 19, 2007, the Bayer management presented the future strategy of Bayer HealthCare to the invited financial analysts at the Bayer Investor Day in Leverkusen, Germany. more

---

02/06/2007
Bayer Responds to study and commentary published in Journal of American Medical Association (JAMA)
Bayer has conducted a preliminary review of the observational study entitled “Mortality Associated with Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery” by Mangano et al. as well as the editorial by T. Bruce Ferguson, Jr., MD from the East Carolina University, Greenville, scheduled for publication on February 7, 2007 in the Journal of the American Medical Association (JAMA) regarding long-term mortality rates in coronary artery bypass graft surgery patients including those treated with aprotinin. more

---

05/31/2007
Patients in Europe need early access to modern medicines
Arthur J. Higgins, the new EFPIA President, calls on all stakeholders to work together to create healthcare systems for the 21st century
The General Assembly of the European Federation of Pharmaceutical Industries and Associations (EFPIA) has elected Arthur J. Higgins, Chairman of the Board of Management of Bayer HealthCare AG, as its new President. more